Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The aim of this call is to fund ground-breaking translational research on malignant lymphoma, malignant lymphoid neoplasia and related malignant blood diseases (particularly lymphoid disorders). Projects will be considered eligible that enhance our understanding and furnish insights or develop tools that will advance the treatment.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: cbarnwell@imim.es Ext.1670
Marta López: mlopez4@imim.es, Ext.: 1576
Convocatòria (URL)
https://www.lymph-co.com/en/research-and-grants/lymphco-research-grant/
Informació addicional
There will be a two-stage submission procedure for applications:
  • Pre-proposals: deadline June 8, 2021.
  • Full proposals: for selected consortia only. Deadline October 27, 2021.
  • Requisits
    Applications from individual researchers or research groups are welcome. Investigators (national or international) involved in translational research on lymphoma are invited to submit a research proposal. In particular, collaborative research proposals from various scientific groups (national and/or international) with complementing expertise are encouraged to apply for a research grant. The main applicant must be employed by a university, university hospital or research organization. Commercial parties are not eligible for funding.
    Dotació
    Applications for funding for personnel and materials/infrastructure have a maximum of 1.5 M€.
    Durada
    Maximum 4 years.

    Arxius

    Arxiu
    Call-for-proposals-LymphCo-Research-Grant-2021.pdf
    Terms-and-conditions-LymphCo-2021.pdf
    LymphCo-Preproposal-grant-application-form-2021-2022.docx